Recruiting OBSERVATIONAL NCT06397859

Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrhosis (SAVE-D)

Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrhosis (SAVE-D Study)

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Conditions Hepatitis D

Interventions Bulevirtide

Updated 4 times since 2024 Last updated: Jun 14, 2024 Started: May 6, 2024 Primary completion: Jun 30, 2026 Completion: Aug 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06397859, this observational or N/A phase trial focuses on Hepatitis D and remains actively recruiting participants. Sponsored by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, it has been updated 4 times since 2024, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Recruiting
Sep 2024 — Sep 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Jun 2024 — Jul 2024 [monthly]

Not Yet Recruiting

First recorded

May 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Data source: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milan, Italy